Facebook
Twitter
LinkedIn
Forward
Through Thick and Thin: New Horizons in the Management of Hypertrophic Cardiomyopathy
Virtual and In Person Activity
This activity is available to Houston Methodist employees and students only.
Target Audience
Pharmacists
This activity is open to all Houston Methodist health care professionals.
Learning Objectives
1. Differentiate between the hallmark features of obstructive and non-obstructive hypertrophic cardiomyopathy (HCM)
2. Develop an evidence-based pharmacotherapy treatment plans for patients with HCM
3. Evaluate the role of cardiac myosin inhibitors in patients with HCM
The Zoom link will be provided in the course instructions when you log in to the program.
Speaker:
Zoe Tu, PharmD
PGY1 Pharmacy Resident
Van Anh Le, PharmD, BCPS
The speaker and preceptors do not have anything to disclose in relation to the subject matter of this presentation.
Houston Methodist Hospital is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Participants documenting completion of the activity by attending the lecture, participating in the learning assessment, and completing an evaluation form within 30 days will receive 1.0 contact hour (0.1 CEU) of continuing pharmacy education credit as an application-based activity for pharmacists.
Available Credit
- 1.00 ACPE Pharmacist
Houston Methodist Hospital is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Participants documenting completion of the activity will receive up to 1.00 contact hours of continuing pharmacy education credit as activities for pharmacists.
- 1.00 Attendance